Study The rate of cervical cancer is reduced by 87% in those vaccinated against the human papillomavirus
Research They discover that the human papillomavirus could also cause prostate cancer
In Spain today there are some 266,000 12-year-olds who are candidates to be vaccinated against a
virus that will be
responsible for genital warts and tumors of the penis and anus
throughout their lives
.
Not only with the vaccine against the human papillomavirus will they overcome these health problems, but they will also help to
cut off the transmission of the pathogen in sexual relations
.
In twenty European countries, thirty in the world, there is health coverage for this puncture.
Catalonia
has recently announced that from next year
it will include it in the calendar
and Galicia follows in its wake.
The vaccine is recommended by the Vaccine Committee of the Spanish Association of Pediatrics (AEP), but
Spanish parents have to pay the cost of the two doses if they have a son
, a fact that does not happen with girls.
Health sources assure this newspaper that the Health Vaccines Report is already studying taking this step, and even dare to say that it
could be a reality by 2023
.
Since 2006 this vaccine has been approved, but only in women.
Federico Martinón-Torres, member of the Advisory Committee on Vaccines of the World Health Organization and head of Pediatrics at the University Clinical Hospital of Santiago: "
HPV infects both women and men
, producing both asymptomatic infections, such as
genital warts
, as well as some cases,
cancers
."
The importance of preventing sexually transmitted infections (STIs) is that 85-90% of sexually active men and women will acquire HPV at some point in their lives.
"That is why it is important that boys and girls receive the two doses of the vaccine before the age of 15, before they have their first relationships," underlines José Manuel Moreno, medical director and co-director of the Department of Pediatrics at the University Clinic. of Navarre.
The AEP advises the use of the 9-
valent vaccine
(against the nine most common subtypes of the pathogen), "although since 2016 we have recommended
informing families of the option of using this vaccine for their sons
", points out Ángel Hernández -Merino, advisor to the Vaccines Committee of the AEP.
Faced with this situation, Martinón-Torres explains that "until now we had focused mainly on
cervical
cancer , the most frequent, and exclusive to women.
Cancers of the penis or anus, also related to HPV and that affect the male
, are less frequent, but they lack alternative detection systems that allow us to carry out secondary prevention".
Pediatricians and vaccine experts have been recommending HPV vaccination for boys for four years now.
Hernández-Merino says that "we already know that
the impact is multiplied when both sexes are immunized
."
He does not hesitate to point out that there are more than twenty countries in the world that include it because "above all it is effective and safe", but also because in the medium term "
it will allow us to truly eradicate lesions responsible for the development of tumors
".
For this reason, Moreno points out that "in this time we have seen that the vaccine has a clear utility in the prevention of precancerous lesions and this has led to a drop in the incidence of tumor cases in women."
In this sense, Martinón-Torres adds that "although they are only related to the virus in 25-30% of cases, they are on the rise, and account for a very significant number of tumors, both in men and women, and as a whole, there are already countries in which this cancer is more frequent than that of the cervix".
The data from the National Epidemiological Surveillance Network provided by the AEP from Health point out that
coverage in girls is 82.4%
, "in boys, although the vaccine can be given for payment, there is no good record of the doses that are given and there is a lot of disparity between communities," explains Hernández-Merino.
Another problem is that there are
four autonomies that have not provided data
on their territories, without any explanation of the causes:
Aragon, the Balearic Islands, the Canary Islands and Castilla y León
.
In the case of Aragon and the Balearic Islands, the lack of transparency on vaccination coverage "has been going on for years. And we have not been able to save that stumbling block," the AEP spokesman emphasizes.
Science has shown in recent years the usefulness of the vaccine as a preventive weapon.
"We are not yet certain that
male vaccination will allow us to achieve the goal of controlling head and neck cancer
, although this is likely to be the case. We are currently collecting data and actively monitoring whether in the first cohorts of subjects vaccinated against HPV are also reducing these tumors, which will give us the definitive scientific evidence", explains Martinón-Torres.
In general,
for every two HPV-related cancers that occur in women, one case occurs in men
.
"Therefore, the importance continues to be significantly greater in women, but it is by no means negligible in men. In
homosexual men
, the incidence of pathology related to human papillomavirus is
even higher
, which makes them a group of particularly high risk, which is why this indication is also free in our country, as is the indication in women".
All the experts say that also immunizing men against HPV "would be desirable
for equity, due to the direct health impact on men
, and because it would
allow us to accelerate the benefits in the female population by
managing to control the circulation of the virus earlier and, therefore, therefore, advance the elimination of cervical cancer, the objective set by the WHO", point out both Martinón-Torres and Hernández-Merino.
Taking this step means
not losing sight of the objective of vaccinating 100% of the girls covered by the vaccination calendar
and "we must also actively rescue and vaccinate all the girls or women who, due to hoaxes, unfounded fears or manipulation, left to get vaccinated on the day," Moreno points out.
In summary, as Martinón-Torres concludes, "vaccinating men can allow us to accelerate the global benefits of vaccination, but also protect them equitably. It is a strategic opportunity for public health, without a doubt."
Conforms to The Trust Project criteria
Know more
cancer
Vaccines